Class-action suit against Merck puts common drugmaker defense to Supreme Court test

(By Alia Paavola for Becker’s Hospital Review)

The U.S. Supreme Court will consider a case next week that examines a legal strategy drugmakers use to defend themselves against patient lawsuits, according to STAT.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.